Case Summary:

A postdoctoral fellow in the field of infectious diseases approached us with a proposed endeavor to use a glycoimmunology approach to understand and address HIV which seemed relevant to healthcare research, virology, and the medical field as a whole. . Though researchers understand much more about this disease than they did when it first emerged, much remains to be done, her research thus engages with this and related questions directly. This helped us establish the fact that her research was of value to the United States. Based on this, we strategize our approach to her I-140 NIW (National Interest Waiver) petition.

We went ahead and accumulated detailed information about her academic and professional background. We saw to it that her needs were understood as were those of the NIW criteria set by USCIS. This became feasible due to our expansive experience in the field, having helped some 25,000+ clients receive optimistic outcomes in their respective cases. We thus included some of the following things in her customized petition packet.

We highlighted that she has obtained a Ph.D. in infectious diseases and her research has resulted in 23 peer-reviewed journal articles (8 of them first-authored or co-first authored). In addition to this, she has been a reviewer for 2 journals and has already conducted at least 4 reviews to date. Also, according to Google Scholar, her publications have been cited a total of 143 times thereby confirming that her publications are widely recognized and relied upon in the field of infectious diseases.

Moreover, we added four recommendation letters to her petition packet. Extraordinary researchers from elite institutions confirm our client’s use of innovative methodologies, the nature of her breakthroughs, and the ways that her unique findings have been applied throughout the field. Two of the experts had the following to say about her:

“Considering the focus of [client’s] research on HIV co-infections, she is a highly valuable asset to the United States. She has conducted research on HIV co-infections with the aforementioned diseases that have resulted in an improved understanding of why HIV-infected individuals are at a greater risk for these diseases. Consequently, [client’s] research is of great importance to HIV-positive Americans who have higher risks of contracting other diseases like EBV, KSHV, and HCV”

“[Client’s] studies on thalidomide and auranofin have provided new insight into the use of the drugs to treat and even cure HIV, which is a major development. For these reasons, [client] must be provided the opportunity to continue her research in the United States to further investigate therapeutic approaches for HIV, which improves the lives of millions of people around the world.”

As demonstrated by the above evidence, our client’s proposed endeavor also has national importance as the WHO estimates that about 38 million people worldwide have HIV, our client’s research represents a valuable contribution to efforts to more effectively address HIV.

All of these factors aided by the excellent case preparation strategy employed by our experts, helped her obtain her NIW (National Interest Waiver) application approval. We are grateful to her for her continued trust in us. We wish her the very best in her life.